Two Sigma Advisers’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Buy |
|
|||||
|
2025
Q1 | $211K | Sell |
|
|||||
|
2024
Q4 | $414K | Sell |
|
|||||
|
2024
Q3 | $1.14M | Sell |
|
|||||
|
2024
Q2 | $1.5M | Buy |
|
|||||
|
2024
Q1 | $1.49M | Sell |
|
|||||
|
2023
Q4 | $1.38M | Sell |
|
|||||
|
2023
Q3 | $2.52M | Buy |
|
|||||
|
2023
Q2 | $1.12M | Buy |
|
|||||
|
2023
Q1 | $968K | Sell |
|
|||||
|
2022
Q4 | $1.82M | Sell |
|
|||||
|
2022
Q3 | $2.52M | Sell |
|
|||||
|
2022
Q2 | $2.42M | Sell |
|
|||||
|
2022
Q1 | $3.1M | Sell |
|
|||||
|
2021
Q4 | $4.33M | Buy |
|
|||||
|
2021
Q3 | $2.94M | Buy |
|
|||||
|
2021
Q2 | $1.6M | Buy |
|
|||||
|
2021
Q1 | $524K | Buy |
|
|||||
|
2020
Q4 | $319K | Buy |
|
|||||
|
2020
Q3 | $193K | Buy |
|
|||||
|
2020
Q2 | $207K | Buy |
|